Henrik J Ditzel Selected Research

Paclitaxel (Taxol)

11/2015	Corrigendum: IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.
10/2015	IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrik J Ditzel Research Topics

Disease

85	Neoplasms (Cancer) 01/2024 - 06/2002
57	Breast Neoplasms (Breast Cancer) 02/2023 - 09/2002
24	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2009
11	Triple Negative Breast Neoplasms 01/2024 - 09/2012
9	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2011
9	Testicular Neoplasms (Testicular Cancer) 01/2020 - 04/2007
6	Melanoma (Melanoma, Malignant) 01/2020 - 10/2008
5	Carcinogenesis 02/2023 - 01/2014
5	Disease Progression 01/2022 - 07/2012
4	COVID-19 10/2023 - 01/2021
4	Carcinoma (Carcinomatosis) 01/2022 - 01/2016
2	Lymphoma (Lymphomas) 05/2024 - 12/2019
2	Adenocarcinoma 01/2020 - 06/2002
2	Brain Neoplasms (Brain Tumor) 01/2018 - 09/2017
2	Lung Neoplasms (Lung Cancer) 01/2017 - 01/2015
2	Multiple Myeloma 09/2013 - 05/2013
2	Arthritis (Polyarthritis) 10/2006 - 02/2004
1	Frailty 11/2023
1	Adenocarcinoma of Lung 05/2023
1	Bites and Stings (Sting) 01/2022
1	Hypoxia (Hypoxemia) 01/2022

Drug/Important Bio-Agent (IBA)

33	Proteins (Proteins, Gene)FDA Link 05/2023 - 09/2002
19	Estrogen ReceptorsIBA 02/2023 - 01/2007
18	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2012
14	Tamoxifen FDA LinkGeneric 01/2021 - 01/2012
13	AntigensIBA 01/2020 - 09/2002
10	Messenger RNA (mRNA)IBA 10/2023 - 01/2012
10	MicroRNAs (MicroRNA)IBA 07/2021 - 10/2011
8	Fulvestrant (Faslodex)FDA Link 02/2023 - 12/2013
8	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2012
6	AntibodiesIBA 01/2015 - 02/2004
5	Letrozole (Femara)FDA LinkGeneric 01/2021 - 03/2012
5	Formaldehyde (Formol)FDA Link 01/2019 - 01/2013
5	ParaffinIBA 01/2019 - 01/2013
5	ProteomeIBA 11/2015 - 11/2009
4	ErbB Receptors (EGF Receptor)IBA 01/2022 - 12/2013
4	Monoclonal AntibodiesIBA 01/2022 - 10/2007
4	EnzymesIBA 01/2022 - 06/2006
4	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2017
3	Chimeric Antigen ReceptorsIBA 05/2024 - 06/2015
3	Aromatase InhibitorsIBA 02/2023 - 12/2015
3	RNA (Ribonucleic Acid)IBA 12/2022 - 11/2019
3	ChromatinIBA 01/2022 - 01/2012
3	Indicators and Reagents (Reagents)IBA 01/2018 - 10/2007
3	Estrogens (Estrogen)FDA Link 08/2016 - 12/2013
3	Hormones (Hormone)IBA 06/2015 - 03/2012
3	Membrane Proteins (Integral Membrane Proteins)IBA 07/2010 - 10/2007
3	AutoantibodiesIBA 12/2009 - 08/2003
2	CyclinsIBA 09/2022 - 01/2021
2	InterferonsIBA 01/2022 - 06/2015
2	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2020
2	CollagenIBA 01/2022 - 03/2016
2	Circulating Tumor DNAIBA 10/2021 - 01/2018
2	CholesterolIBA 01/2021 - 01/2019
2	VaccinesIBA 01/2020 - 10/2013
2	Phosphotransferases (Kinase)IBA 01/2020 - 11/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 01/2019
2	MethyltransferasesIBA 01/2020 - 01/2015
2	Complement System Proteins (Complement)IBA 01/2018 - 12/2009
2	Immunoglobulin FragmentsIBA 03/2016 - 10/2007
2	Docetaxel (Taxotere)FDA Link 01/2016 - 06/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2015 - 10/2015
2	Small Interfering RNA (siRNA)IBA 11/2015 - 10/2013
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2013 - 05/2013
2	Nonesterified Fatty Acids (NEFA)IBA 01/2012 - 08/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2012 - 08/2010
2	Antigen-Antibody Complex (Immune Complex)IBA 10/2006 - 12/2004
2	Immunoglobulin G (IgG)IBA 10/2006 - 08/2003
1	atezolizumabIBA 01/2024
1	mRNA VaccinesIBA 10/2023
1	Combined VaccinesIBA 10/2023
1	BNT162 VaccineIBA 10/2023
1	Conditioned Culture MediaIBA 05/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023
1	c-Mer Tyrosine KinaseIBA 05/2023
1	Interleukin-10 (Interleukin 10)IBA 05/2023
1	Interleukin-4 (Interleukin 4)IBA 05/2023
1	Protein Isoforms (Isoforms)IBA 02/2023
1	AlpelisibIBA 02/2023
1	capivasertibIBA 02/2023
1	ChemokinesIBA 12/2022
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2022
1	Aromatase (CYP19)IBA 09/2022
1	Aurora Kinase AIBA 09/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Adenosine (Adenocard)FDA LinkGeneric 01/2022
1	p38 Mitogen-Activated Protein KinasesIBA 12/2021
1	3' Untranslated Regions (3' UTR)IBA 07/2021
1	Minichromosome Maintenance ProteinsIBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2020
1	DNA-Binding Proteins (DNA Binding Protein)IBA 03/2020
1	Dihydroorotate DehydrogenaseIBA 01/2020
1	Biological FactorsIBA 01/2020

Therapy/Procedure

35	Therapeutics 01/2024 - 10/2007
13	Immunotherapy 01/2024 - 10/2007
6	Drug Therapy (Chemotherapy) 01/2020 - 03/2012
1	Palliative Care (Palliative Therapy) 11/2023